Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Rull

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 29, 2024
The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic functionVanesa Garrido-Rodríguez, Ángel Bulnes-Ramos, Israel Olivas-Martínez, et al.
Plos One|March 20, 2012
The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studiesAhmed Djeghader, Gerard Aragonès, Nune Darbinian, et al.
Clinical and Translational Medicine|July 29, 2021
Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllersJenifer Masip, Carmen Gasca-Capote, María Reyes Jimenez-Leon, et al.
Medical Microbiology and Immunology|December 26, 2024
Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal studyElena Vazquez-Alejo, María De La Sierra Espinar-Buitrago, Esmeralda Magro-Lopez, et al.
AIDS (London, England)|December 28, 2017
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patientsEsther Rodríguez-Gallego, Josep Gómez, Yolanda M Pacheco, et al.
The Journal of Infection|April 30, 2026
Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoirPaula Suanzes, Judith Grau-Expósito, Jordi Navarro, et al.
Frontiers in Immunology|October 3, 2022
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomesVictòria Ceperuelo-Mallafré, Laia Reverté, Joaquim Peraire, et al.
Ebiomedicine|November 9, 2020
High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsElena Yeregui, Consuelo Viladés, Pere Domingo, et al.
Atherosclerosis|April 21, 2018
Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapyEsther Rodríguez-Gallego, Josep Gómez, Pere Domingo, et al.
Scientific Reports|November 2, 2019
IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery statusAndra Ceausu, Esther Rodríguez-Gallego, Joaquim Peraire, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 29, 2024
The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic functionVanesa Garrido-Rodríguez, Ángel Bulnes-Ramos, Israel Olivas-Martínez, et al.
Plos One|March 20, 2012
The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studiesAhmed Djeghader, Gerard Aragonès, Nune Darbinian, et al.
Clinical and Translational Medicine|July 29, 2021
Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllersJenifer Masip, Carmen Gasca-Capote, María Reyes Jimenez-Leon, et al.
Medical Microbiology and Immunology|December 26, 2024
Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal studyElena Vazquez-Alejo, María De La Sierra Espinar-Buitrago, Esmeralda Magro-Lopez, et al.
AIDS (London, England)|December 28, 2017
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patientsEsther Rodríguez-Gallego, Josep Gómez, Yolanda M Pacheco, et al.
The Journal of Infection|April 30, 2026
Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoirPaula Suanzes, Judith Grau-Expósito, Jordi Navarro, et al.
Frontiers in Immunology|October 3, 2022
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomesVictòria Ceperuelo-Mallafré, Laia Reverté, Joaquim Peraire, et al.
Ebiomedicine|November 9, 2020
High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsElena Yeregui, Consuelo Viladés, Pere Domingo, et al.
Atherosclerosis|April 21, 2018
Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapyEsther Rodríguez-Gallego, Josep Gómez, Pere Domingo, et al.
Scientific Reports|November 2, 2019
IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery statusAndra Ceausu, Esther Rodríguez-Gallego, Joaquim Peraire, et al.
Pageof 10